Literature DB >> 6310099

Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells.

R Casteels, I S Login.   

Abstract

The effects of reserpine on excitation-contraction coupling and 45Ca exchange of smooth muscle cells of the rabbit ear artery and the guinea-pig taenia coli have been studied. Reserpine inhibited the spontaneous mechanical activity of the taenia coli and the force development induced by 59 mM-external K or 10(-5) M-carbachol. In the ear artery reserpine blocked the K-induced contraction but its effect on the contraction elicited by noradrenaline was smaller. At 0.2 mM-Ca, the inhibition of the tonic component of the noradrenaline-induced contraction was more pronounced than that of the phasic component. This reserpine action was fully reversible for the noradrenaline stimulus in the ear artery but less so for K-induced contractions. The inhibitory action on contractions induced in taenia coli by K-rich solution and by carbachol was even less reversible. The analysis of the effect of reserpine on the 45Ca exchange in the ear artery has revealed that it inhibits the increase of the fractional loss induced by K depolarization, but that it does not exert a significant effect on the increased fractional loss induced by 10(-5) M-noradrenaline. Reserpine slows down the filling with 45Ca of the agonist-sensitive store without affecting the steady-state amount of Ca taken up by the store. A study of the degree of filling of the store by measuring the force development and the 45Ca release elicited by noradrenaline in Ca-free medium, reveals that the force development after loading in a reserpine-containing medium remains less than the control, although the same amount of Ca is released from the store. It was shown by using tetrabenazine that the inhibitory action of reserpine on the Ca exchange and the force development is not due to an interaction of reserpine with the receptor molecules that are responsible for its depleting action on aminergic granules. These results strongly suggest that reserpine exerts a Ca antagonistic action on smooth muscle whereby it blocks the potential-dependent channels. However, reserpine also affects the receptor-operated channels to some extent and in addition at a high concentration it seems to exert an unspecific inhibitory action on the contractile system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310099      PMCID: PMC1199216          DOI: 10.1113/jphysiol.1983.sp014769

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  "Direct" effect of reserpine on various preparations.

Authors:  F Zonta; G D'Agostino; A Lucchelli; E Grana
Journal:  Farmaco Sci       Date:  1976-12

Review 2.  Transport and storage of biogenic amines.

Authors:  P A Shore
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

3.  Reserpine-induced release of norepinephrine from isolated spontaneously beating guinea-pig atria.

Authors:  S Brimijoin; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1971-01       Impact factor: 4.030

4.  Biphasic vasoconstriction of the rabbit ear artery.

Authors:  O S Steinsland; R F Furchgott; S M Kirpekar
Journal:  Circ Res       Date:  1973-01       Impact factor: 17.367

5.  Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.

Authors:  J T Willerson; R H Thompson; P Hookman; J Herdt; J L Decker
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

6.  The chronically reserpinized rat as a possible model for cystic fibrosis. VII. Alterations in the secretory response to cholecystokinin and to secretin from the pancreas in vivo.

Authors:  J Perlmutter; J R Martinez
Journal:  Pediatr Res       Date:  1978-03       Impact factor: 3.756

7.  Abnormal secretory response to parasympathomimetic and sympathomimetic stimulations from the submaxillary gland of rats treated with reserpine.

Authors:  J R Martinez; D O Quissell; D L Wood; M Giles
Journal:  J Pharmacol Exp Ther       Date:  1975-08       Impact factor: 4.030

8.  Electro- and pharmacomechanical coupling in the smooth muscle cells of the rabbit ear artery.

Authors:  G Droogmans; L Raeymaekers; R Casteels
Journal:  J Gen Physiol       Date:  1977-08       Impact factor: 4.086

9.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

10.  Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.

Authors:  G P QUINN; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

View more
  3 in total

Review 1.  Ca-exchange, Ca-channels and Ca-antagonists.

Authors:  G Droogmans; B Himpens; R Casteels
Journal:  Experientia       Date:  1985-07-15

2.  Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF.

Authors:  J Morisset; F L Bérubé; M Vanier; O Benrezzak
Journal:  Int J Pancreatol       Date:  1994-08

3.  Norepinephrine as a possible transmitter involved in synaptic transmission in frog taste organs and Ca dependence of its release.

Authors:  S Nagahama; K Kurihara
Journal:  J Gen Physiol       Date:  1985-03       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.